UICC Opens the World Cancer Leaders’ Summit 2025

World Cancer Leaders UICC

“Delivering Innovation with Integrity” - ACT 4 Children Initiative at the 2025 WCLS

ACT 4 Children

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

Pediatric Cardio-Oncology Consortium to Host Virtual Summit on December 4, 2025

Cardio-Oncology-Consortium

2025 Selected Abstracts for the European Cancer Summit - European Cancer Organisation

European Cancer Organisation European Cancer Summit

FDA Approves Ziftomenib (Komzifti) for Relapsed or Refractory NPM1-Mutated Acute Myeloid Leukemia

ziftomenib

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

The World’s First Trial of a Vaccine to Prevent Lung Cancer - Cancer Research UK

Cancer Research UK

OncoCalendar

« All Events

  • This event has passed.

The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO

Mar 1 • 12:00 AM - Mar 5 • 12:00 AM
ESTRO Webinar Series

The Nordic Radiotherapy Diploma Programme (NORTHDIP) for Clinical Oncologists by ESTRO will be going on for two years from March 2025 to November 2026.

The Nordic Radiotherapy Diploma Programme (NORTHDIP) is a two-year advanced education initiative designed for clinical oncologists across the Nordic countries: Denmark, Iceland, Finland, Norway, and Sweden. The programme addresses the need for supplementary radiotherapy training for oncologists who specialize in radiotherapy after their clinical oncology education.

The goal of NORTHDIP is to enhance radiotherapy skills and foster collaboration among Nordic clinical oncologists, ultimately advancing expertise in the region and promoting collaborative research and development in radiotherapy.

The programme’s content is aligned with ESTRO’s core curriculum for radiation oncologists and covers a variety of advanced topics:

  • Sweden 2024: Advanced radiophysics, dose planning, organs-at-risk constraints, and advanced technologies.
  • Norway 2025: Radiobiology, benign diseases, and palliative care.
  • Finland 2025: Reirradiation, stereotactic radiotherapy, and BNCT (Boron Neutron Capture Therapy).
  • Denmark 2026: Adaptive radiotherapy and imaging (CBCT, dual-energy CT, PET-CT, MRI), including the integration of proton and MR-Linac therapy.
  • Iceland 2026: Nordic research protocols, including the design of clinical trials for collaborative Nordic implementation and shared patient recruitment.

Details

Organizer